5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy

The tumour-associated antigen 5T4 is an attractive target for cancer immunotherapy. However to date, reported 5T4-specific cellular immune responses induced by various immunisation platforms have been largely weak or non-existent. In the present study, we have evaluated a heterologous prime boost re...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappuccini, Federica, Pollock, Emily, Stribbling, Stephen, Hill, Adrian V.S., Redchenko, Irina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564579/
https://www.ncbi.nlm.nih.gov/pubmed/28537896
http://dx.doi.org/10.18632/oncotarget.17666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564579/
https://www.ncbi.nlm.nih.gov/pubmed/28537896
http://dx.doi.org/10.18632/oncotarget.17666

Ejemplares similares